THROMBOEMBOLIC RISKS ASSOCIATED WITH THE USE OF HORMONAL CONTRACEPTIVES: INTEGRATIVE REVIEW

Authors

  • Alessandra Fernandes Gomes Centro Universitário Santa Maria - UNIFSM
  • José Guilherme Ferreira Marques Galvão Centro Universitário Santa Maria - UNIFSM
  • Ana Emília Formiga Marques Centro Universitário Santa Maria - UNIFSM
  • Diego Igor Alves Fernandes de Araújo Universidade Federal da Paraíba https://orcid.org/0000-0002-8032-6240

DOI:

https://doi.org/10.61164/tqyvzh73

Keywords:

venous thrombosis, hormonal contraceptives, progestin, estrogen, risks

Abstract

Hormonal contraceptives have been widely used in Brazil since the 1960s and are effective in contraception and in treating various conditions, such as dysmenorrhea and acne. However, their use is associated with the risk of thromboembolic events, such as Deep Vein Thrombosis (DVT), due to the action of hormones (progesterone and estrogen) on blood clotting. In addition to hormonal contraceptives, factors that influence this risk include genetic predisposition, obesity, smoking, and age. This work is an integrative literature review. Data collection was carried out through the selection of scientific articles published between 2019 and November 2025, in the databases Latin American and Caribbean Literature in Health Sciences (LILACS), PubMed, Scientific Electronic Library Online (SciELO), using descriptors extracted from DeCS (Descriptors in Health Sciences), based on the keywords: Venous Thrombosis; Hormonal Contraceptives; risks. After applying the previously established inclusion criteria, 8 articles were selected for use in the analysis and discussion of this work. The results indicate that the use of combined hormonal contraceptives is associated with a significant increase in the risk of venous thromboembolism, especially in women with predisposing factors. Among the different types of progestogens, some have a higher thrombogenic potential, such as desogestrel and drospirenone, as do estrogens at higher doses. It is concluded that, although effective in contraception, these medications require individualized evaluation. Therefore, this study aims to provide support for healthcare professionals and women in choosing safe contraceptive methods, balancing contraceptive efficacy and the reduction of cardiovascular risks.

Downloads

Download data is not yet available.

References

ABOU-ISMAIL, Mouhamed Yazan; SRIDHAR, Divyaswathi Citla; NAYAK, Lalitha. Estrogênio e trombose: uma revisão da bancada à beira do leito. Pesquisa em trombose , v. 192, p. 40-51, 2020. DOI: https://doi.org/10.1016/j.thromres.2020.05.008

ALSHEEF, Mohammed et al. Combined oral contraceptives and vascular thrombosis: a single-center experience. Cureus, v. 14, n. 6, 2022. DOI: https://doi.org/10.7759/cureus.25865

BARCELLONA, Doris; MARONGIU, Francesco; GRANDONE, Elvira. Contraceptives and thrombosis: an intertwined revolutionary road. In: Seminars in Thrombosis and Hemostasis. Thieme Medical Publishers, Inc., 2024. p. 091-095. DOI: https://doi.org/10.1055/s-0043-1764382

BARCELLONA, Doris; GRANDONE, Elvira; MARONGIU, Francesco. Hormones and thrombosis: the dark side of the moon. Blood Transfusion, v. 22, n. 1, p. 46, 2023.

BARROS, Venina Isabel Poço Viana Leme de et al. Use of hormones and risk of venous thromboembolism. Revista Brasileira de Ginecologia e Obstetrícia, v. 46, p. e-FPS02, 2024. DOI: https://doi.org/10.61622/rbgo/2024FPS02

BLACK, Kirsten I.; VROMMAN, Maxime; FRENCH, Rebecca S. Common myths and misconceptions surrounding hormonal contraception. Best Practice & Research Clinical Obstetrics & Gynaecology, p. 102573, 2024. DOI: https://doi.org/10.1016/j.bpobgyn.2024.102573

FONSECA JUNIOR, Alexandre Agustavo et al. Trombose venosa profunda: aspectos epidemiológicos, fisiopatológicos e manejo terapêutico. Brazilian Journal of Development, v. 9, n. 05, p. 15041-15052, 2023. DOI: https://doi.org/10.34117/bjdv9n5-039

GENAZZANI, Andrea R. et al. Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice. Gynecological Endocrinology, v. 39, n. 1, p. 2247093, 2023. DOI: https://doi.org/10.1080/09513590.2023.2247093

GONDIM, Ana Caroline Santos; ALMEIDA, Camila Santos Alves de; PASSOS, Marco Aurélio Ninomia. Influência do anticoncepcional hormonal oral no surgimento da trombose venosa profunda. REVISA, [S. l.], v. 11, n. 2, p. 120-126, 2022. Disponível em: https://rdcsa.emnuvens.com.br/revista/article/view/267. Acesso em: 24 mar. 2025. DOI: https://doi.org/10.36239/revisa.v11.n2.p120a126

HEIKINHEIMO, Oskari et al. Systemic hormonal contraception and risk of venous thromboembolism. Acta obstetricia et gynecologica Scandinavica, v. 101, n. 8, p. 846-855, 2022. DOI: https://doi.org/10.1111/aogs.14384

LAGO, Adria Cristina Viana et al. Risco de trombose venosa relacionada ao uso de anticoncepcionais orais. Research, Society and Development, v. 11, n. 16, p. e158111638150-e158111638150, 2022. DOI: https://doi.org/10.33448/rsd-v11i16.38150

LAVASSEUR, Corinne et al. Hormonal therapies and venous thrombosis: Considerations for prevention and management. Research and practice in thrombosis and haemostasis, v. 6, n. 6, p. e12763, 2022. DOI: https://doi.org/10.1002/rth2.12763

LINNEMANN, Birgit et al. Venous thromboembolism issues in women. Hämostaseologie, v. 42, n. 05, p. 290-299, 2022. DOI: https://doi.org/10.1055/a-1919-9558

MENDES, Karina Dal Sasso; SILVEIRA, Renata Cristina de Campos Pereira; GALVÃO, Cristina Maria. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto Enfermagem, Florianópolis, v. 17, n. 4, p. 758-764, out./dez. 2008. Disponível em: https://doi.org/10.1590/S0104-07072008000400018. Acesso em: 20 mar. 2025. DOI: https://doi.org/10.1590/S0104-07072008000400018

MORIMONT, Laure et al. Contraceptivos orais combinados e tromboembolismo venoso: revisão e perspectiva para mitigar o risco. Frontiers in endocrinology , v. 12, p. 769187, 2021.

OLIVEIRA, André Luiz Malavasi Longo de; PASCHÔA, Adilson Ferraz; MARQUES, Marcos Arêas. Tromboembolismo venoso na mulher: novos desafios para uma velha doença. Jornal Vascular Brasileiro, v. 19, p. e20190148, 2020. DOI: https://doi.org/10.1590/1677-5449.190148

SKEITH, Leslie; BATES, Shannon M. Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices. Hematology, v. 2024, n. 1, p. 644-651, 2024. DOI: https://doi.org/10.1182/hematology.2024000591

SILVA, Celi Santos da; SÁ, Rosiane; TOLEDO, Juliana. Métodos Contraceptivos e Prevalência de Mulheres Adultas e Jovens com risco de Trombose, no Campus Centro Universitário do Distrito Federal-UDF. REVISA, [S. l.], v. 8, n. 2, p. 190-197, 2019. Disponível em: https://rdcsa.emnuvens.com.br/revista/article/view/682. Acesso em: 28 mar. 2025. DOI: https://doi.org/10.36239/revisa.v8.n2.p190a197

SOBREIRA, Marcone Lima et al. Diretrizes sobre trombose venosa profunda da Sociedade Brasileira de Angiologia e Cirurgia Vascular.Jornal Vascular Brasileiro, v. 23, p. e20230107, 2024. DOI: https://doi.org/10.1590/1677-5449.202301071

SOUZA, M. T.; SILVA, M. D.; CARVALHO, R. Revisão integrativa: o que é e como fazer. Einstein, v. 8, 1 Pt 1, p. 102-106, 2010. DOI: https://doi.org/10.1590/s1679-45082010rw1134

PASTORI, Daniele et al. A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. International journal of molecular sciences, v. 24, n. 4, p. 3169, 2023. DOI: https://doi.org/10.3390/ijms24043169

WILLIAMS, Jennifer S.; MACDONALD, Maureen J. Influence of hormonal contraceptives on peripheral vascular function and structure in premenopausal females: a review. American Journal of Physiology-Heart and Circulatory Physiology, v. 320, n. 1, p. H77-H89, 2021. DOI: https://doi.org/10.1152/ajpheart.00614.2020

Published

2025-12-10

How to Cite

THROMBOEMBOLIC RISKS ASSOCIATED WITH THE USE OF HORMONAL CONTRACEPTIVES: INTEGRATIVE REVIEW. (2025). Revista Multidisciplinar Do Nordeste Mineiro, 21(02), 1-19. https://doi.org/10.61164/tqyvzh73